Pieris Pharmaceuticals, Inc. (PIRS)
PIRS moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How PIRS actually reacts to news — the realized, point-in-time move the market made, measured across 95 labeled events over the last three years with zero look-ahead.
PIRS’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 41% | 46 |
| 30-min | 0.00% | 39% | 57 |
| 60-min | -0.24% | 34% | 65 |
| to close | 0.00% | 49% | 69 |
| Middle 50% of PIRS reactions | -1.38% to +1.63% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 95 |
Half of all Pieris Pharmaceuticals, Inc. news events land between -1.38% and +1.63% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when PIRS moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to PIRS's baseline. Nothing else.
Recent PIRS events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K PALVELLA THERAPEUTICS, For: Dec 13 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form SEC STAFF LETTER PIERIS PHARMACEUTICALS, | SEC filing · Form SEC | SEC EDGAR | — | -4.76% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Dec 11 | SEC filing · Form 8-K | SEC EDGAR | +1.59% | -9.99% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Dec 02 | SEC filing · Form 8-K | SEC EDGAR | — | -5.24% | |
| Form 10-Q PIERIS PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | -0.37% | |
| Form EFFECT PIERIS PHARMACEUTICALS, | SEC filing · Form EFFECT | SEC EDGAR | — | +1.51% | |
| Form S-4/A PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | SEC EDGAR | — | -0.66% | |
| Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations | Press release | GlobeNewswire | — | -0.66% | |
| Form ARS PIERIS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | — | -0.66% | |
| Form DEF 14A PIERIS PHARMACEUTICALS, For: Dec 02 | SEC filing · Form DEF | SEC EDGAR | — | -0.66% | |
| Form S-4/A PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | SEC EDGAR | +2.21% | -1.79% | |
| Form S-4/A PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | SEC EDGAR | — | -0.29% | |
| Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer | Press release | GlobeNewswire | +0.62% | +1.93% | |
| Form S-4/A PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | SEC EDGAR | +0.68% | +0.87% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Oct 03 | SEC filing · Form 8-K | SEC EDGAR | — | -1.57% | |
| Form S-4/A PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | SEC EDGAR | -1.05% | +0.12% | |
| PIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to Shareholders | Press release | Business Wire | — | -3.39% | |
| Form 10-Q PIERIS PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -1.81% | |
| Form S-4 PIERIS PHARMACEUTICALS, | SEC filing · Form S-4 | SEC EDGAR | +0.00% | +4.82% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.70% | |
| ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Pieris Pharmaceuticals, Inc. | Press release | PR Newswire | -5.22% | +7.58% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | +17.53% | +14.71% | |
| Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement | Press release | Accesswire | +17.53% | +14.71% | |
| PIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to Shareholders | Press release | Business Wire | +3.98% | +14.02% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Jun 28 | SEC filing · Form 8-K | SEC EDGAR | +6.44% | +4.09% | |
| Form 10-Q PIERIS PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +1.17% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: May 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.41% | |
| Form 10-K/A PIERIS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +0.60% | |
| Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split | Press release | Accesswire | -2.68% | -2.75% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Apr 18 | SEC filing · Form 8-K | SEC EDGAR | -3.25% | -5.84% | |
| Form 10-K PIERIS PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.05% | -1.58% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Mar 27 | SEC filing · Form 8-K | SEC EDGAR | +0.58% | +1.95% | |
| Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential | Press release | Accesswire | +0.58% | +1.95% | |
| Form 8-K PIERIS PHARMACEUTICALS, For: Dec 15 | SEC filing · Form 8-K | SEC EDGAR | -4.38% | -1.50% | |
| Form 10-Q PIERIS PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.17% | +0.61% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the PIRS section they belong to.
Where else PIRS is measured.
PIRS earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ORGANIGRAM HOLDINGS INC (OGRMF) | 97 | +0.25% | 56% |
| Utah Medical Products, Inc. (UTMD) | 96 | 0.00% | 48% |
| ASTELLAS PHARMA UNSP/ADR (ALPMY) | 94 | +0.02% | 50% |
| Check-Cap Ltd. - Ordinary Share (CHEK) | 94 | -0.11% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Pieris Pharmaceuticals, Inc.'s median reaction calculated?
Every labeled PIRS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 95 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 39% of PIRS's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does PIRS's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.